Publication of Prospectus

RNS Number : 0464P

BACIT Limited

26 September 2013

 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE OR HONG KONG.

This announcement is an advertisement and not a prospectus. This announcement does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities in BACIT Limited (the "Company") or securities in any other entity, in any jurisdiction, including the United States, nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities. Any investment decision must be made exclusively on the basis of the Prospectus published by the Company and any supplement thereto.

Unless the context requires otherwise, defined terms in this announcement shall have the meanings given to them in the Prospectus.

26 September 2013

BACIT LIMITED

PUBLICATION OF PROSPECTUS

BACIT Limited has today published a prospectus (the "Prospectus") and a circular (the "Circular") in connection with an issue of C Shares (the "Shares") by the Company by way of placing and offer for subscription announced today (the "Offer").

The Prospectus has been approved by the UK Listing Authority. Copies of the Prospectus are available from BACIT Limited's registered office and at www.bacitltd.com and the Prospectus and the Circular will shortly be available for viewing at: www.morningstar.co.uk/uk/nsm.

For further information please contact:

William Simmonds                             

J.P. Morgan Cazenove

0207 588 2828

Rose Toussaint

Northern Trust

01481 745 381

J.P. Morgan Cazenove is acting exclusively for the Company and no one else in connection with the Offer and will not regard any other person (whether or not a recipient of this announcement) as its client and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove nor for giving advice in relation to the Offer, the contents of this announcement or any transaction or arrangement referred to herein.

The Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or any state securities laws in the United States or under the applicable securities laws of Australia, Canada, Japan, South Africa, Singapore or Hong Kong. Subject to certain exceptions, the Shares may not be offered or sold within Australia, Canada, Japan, South Africa, Singapore or Hong Kong. Further, the Shares may not be offered or sold directly or indirectly in or into the United States, or to or for the account or benefit of any U.S. person (as defined in Regulation S under the Securities Act). The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") and investors will not be entitled to the benefits of the Investment Company Act.

The Institute of Cancer Research does not accept any responsibility whatsoever for the contents of this announcement or for any other statement made or purported to be made by it or on its behalf in connection with the Company, the Shares or the Offer.

This announcement may not be distributed, directly or indirectly, in or into or from the United States, Australia, Canada, Japan, South Africa, Singapore or Hong Kong or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. This announcement does not constitute or form part of an offer to sell or issue, or any solicitation of an offer to buy or subscribe for, any securities referred to herein in the United States or in any other jurisdiction. The Offer and the distribution of this announcement and other information in connection with the Offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

 

END

 

 

PDIPGUAABUPWGAQ